These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14741259)

  • 1. Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
    Dinsmore CJ; Zartman CB; Bergman JM; Abrams MT; Buser CA; Culberson JC; Davide JP; Ellis-Hutchings M; Fernandes C; Graham SL; Hartman GD; Huber HE; Lobell RB; Mosser SD; Robinson RG; Williams TM
    Bioorg Med Chem Lett; 2004 Feb; 14(3):639-43. PubMed ID: 14741259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
    Bergman JM; Abrams MT; Davide JP; Greenberg IB; Robinson RG; Buser CA; Huber HE; Koblan KS; Kohl NE; Lobell RB; Graham SL; Hartman GD; Williams TM; Dinsmore CJ
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1411-5. PubMed ID: 11378366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
    Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
    Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
    Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; Etiévant C; Hill B
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
    Nguyen DN; Stump CA; Walsh ES; Fernandes C; Davide JP; Ellis-Hutchings M; Robinson RG; Williams TM; Lobell RB; Huber HE; Buser CA
    Bioorg Med Chem Lett; 2002 May; 12(9):1269-73. PubMed ID: 11965368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase).
    Lee H; Lee J; Lee S; Shin Y; Jung W; Kim JH; Park K; Kim K; Cho HS; Ro S; Lee S; Jeong SW; Choi T; Chung HH; Koh JS
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3069-72. PubMed ID: 11714612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of farnesyltransferase and geranylgeranyltransferase-I for antitumor therapy: substrate-based design, conformational constraint and biological activity.
    Dinsmore CJ; Bell IM
    Curr Top Med Chem; 2003; 3(10):1075-93. PubMed ID: 12769709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.
    Tucker TJ; Abrams MT; Buser CA; Davide JP; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hartman GD; Huber HE; Liu D; Lobell RB; Lumma WC; Robinson RG; Sisko JT; Smith AM
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2027-30. PubMed ID: 12113834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase.
    Dinsmore CJ; Bergman JM; Wei DD; Zartman CB; Davide JP; Greenberg IB; Liu D; O'Neill TJ; Gibbs JB; Koblan KS; Kohl NE; Lobell RB; Chen IW; McLoughlin DA; Olah TV; Graham SL; Hartman GD; Williams TM
    Bioorg Med Chem Lett; 2001 Feb; 11(4):537-40. PubMed ID: 11229765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.
    deSolms SJ; Ciccarone TM; MacTough SC; Shaw AW; Buser CA; Ellis-Hutchings M; Fernandes C; Hamilton KA; Huber HE; Kohl NE; Lobell RB; Robinson RG; Tsou NN; Walsh ES; Graham SL; Beese LS; Taylor JS
    J Med Chem; 2003 Jul; 46(14):2973-84. PubMed ID: 12825937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I.
    Peng H; Carrico D; Thai V; Blaskovich M; Bucher C; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 May; 4(9):1768-84. PubMed ID: 16633570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase.
    Lannuzel M; Lamothe M; Schambel P; Etiévant C; Hill B; Perez M
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1459-62. PubMed ID: 12668012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA.
    Angibaud P; Saha AK; Bourdrez X; End DW; Freyne E; Lezouret P; Mannens G; Mevellec L; Meyer C; Pilatte I; Poncelet V; Roux B; Smets G; Van Dun J; Venet M; Wouters W
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4361-4. PubMed ID: 14643326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.
    Vasudevan A; Qian Y; Vogt A; Blaskovich MA; Ohkanda J; Sebti SM; Hamilton AD
    J Med Chem; 1999 Apr; 42(8):1333-40. PubMed ID: 10212118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massadine, a novel geranylgeranyltransferase type I inhibitor from the marine sponge Stylissa aff. massa.
    Nishimura S; Matsunaga S; Shibazaki M; Suzuki K; Furihata K; van Soest RW; Fusetani N
    Org Lett; 2003 Jun; 5(13):2255-7. PubMed ID: 12816422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors.
    O'Connell CE; Ackermann K; Rowell CA; Garcia AM; Lewis MD; Schwartz CE
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2095-100. PubMed ID: 10450988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
    Williams TM; Ciccarone TM; MacTough SC; Bock RL; Conner MW; Davide JP; Hamilton K; Koblan KS; Kohl NE; Kral AM; Mosser SD; Omer CA; Pompliano DL; Rands E; Schaber MD; Shah D; Wilson FR; Gibbs JB; Graham SL; Hartman GD; Oliff AI; Smith RL
    J Med Chem; 1996 Mar; 39(7):1345-8. PubMed ID: 8691462
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene series.
    Lethu S; Ginisty M; Bosc D; Dubois J
    J Med Chem; 2009 Oct; 52(20):6205-8. PubMed ID: 19772293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.